Four integrated technologies for Biologics developability assessment

December 13, 2022

The decisions you make about your biologics candidates early in the pipeline ultimately affect their success as therapeutics.

Combine sizing and stability information to gain valuable insight into the viability of your protein-based biologic candidates, enabling you to select the best ones for further development.

The technologies inside the Prometheus Panta provide high-quality information about your candidates’ purity, size, thermal stability, and aggregation, which enables better pipeline decisions.

Learn more about how Prometheus Panta helps biologics researchers.

Previous Article
How early discovery and development teams use Dynamic Light Scattering to de⁠-⁠risk downstream biologics development
How early discovery and development teams use Dynamic Light Scattering to de⁠-⁠risk downstream biologics development

As a discovery or early development scientist, you’re tasked with identifying the most promising biologics ...

Up next
The biologics researcher's guide to DLS
The biologics researcher's guide to DLS

Ready to tackle your challenging stability characterizations?

Discover tools